Synthesis and Antiviral Evaluation of Nucleoside Analogues Bearing One Pyrimidine Moiety and Two D-Ribofuranosyl Residues

• Published in: Molecules (Basel, Switzerland) Vol. 26; no. 12; p. 3678
• Main Authors: Andreeva, Olga V., Garifullin, Bulat F., Zarubaev, Vladimir V., Slita, Alexander V., Yesaulkova, Iana L., Volobueva, Alexandrina S., Belenok, Mayya G., Man’kova, Maria A., Saifina, Liliya F., Shulaeva, Marina M., Voloshina, Alexandra D., Lyubina, Anna P., Semenov, Vyacheslav E., Kataev, Vladimir E.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 16-06-2021; MDPI
• Subjects: 1,2,3-triazole; Adenosine; Analogs; Antiviral activity; antivirals; click chemistry; coxsackievirus; DNA-directed RNA polymerase; Fragments; influenza virus; Nitrogen; Nitrogen atoms; Nucleoside analogs; nucleoside analogues; Nucleosides; Propylene; Proteins; RNA-directed RNA polymerase; Swine flu; Thymine; Uracil; Viruses; VP1 protein
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules26123678

A series of 1,2,3-triazolyl nucleoside analogues in which 1,2,3-triazol-4-yl-β-d-ribofuranosyl fragments are attached via polymethylene linkers to both nitrogen atoms of the heterocycle moiety (uracil, 6-methyluracil, thymine, quinazoline-2,4-dione, alloxazine) or to the C-5 and N-3 atoms of the 6-methyluracil moiety was synthesized. All compounds synthesized were evaluated for antiviral activity against influenza virus A/PR/8/34/(H1N1) and coxsackievirus B3. Antiviral assays revealed three compounds, 2i, 5i, 11c, which showed moderate activity against influenza virus A H1N1 with IC50 values of 57.5 µM, 24.3 µM, and 29.2 µM, respectively. In the first two nucleoside analogues, 1,2,3-triazol-4-yl-β-d-ribofuranosyl fragments are attached via butylene linkers to N-1 and N-3 atoms of the heterocycle moiety (6-methyluracil and alloxazine, respectively). In nucleoside analogue 11c, two 1,2,3-triazol-4-yl-2′,3′,5′-tri-O-acetyl-β-d-ribofuranose fragments are attached via propylene linkers to the C-5 and N-3 atoms of the 6-methyluracil moiety. Almost all synthesized 1,2,3-triazolyl nucleoside analogues showed no antiviral activity against the coxsackie B3 virus. Two exceptions are 1,2,3-triazolyl nucleoside analogs 2f and 5f, in which 1,2,3-triazol-4-yl-2′,3′,5′-tri-O-acetyl-β-d-ribofuranose fragments are attached to the C-5 and N-3 atoms of the heterocycle moiety (6-methyluracil and alloxazine respectively). These compounds exhibited high antiviral potency against the coxsackie B3 virus with IC50 values of 12.4 and 11.3 µM, respectively, although both were inactive against influenza virus A H1N1. According to theoretical calculations, the antiviral activity of the 1,2,3-triazolyl nucleoside analogues 2i, 5i, and 11c against the H1N1 (A/PR/8/34) influenza virus can be explained by their influence on the functioning of the polymerase acidic protein (PA) of RNA-dependent RNA polymerase (RdRp). As to the antiviral activity of nucleoside analogs 2f and 5f against coxsackievirus B3, it can be explained by their interaction with the coat proteins VP1 and VP2.